• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体隐性遗传性假性醛固酮减少症患儿的临床特征和治疗需求。

Clinical characteristics and treatment requirements of children with autosomal recessive pseudohypoaldosteronism.

机构信息

Department of Paediatrics, Sandwell and West Birmingham NHS Trust, Birmingham, UK.

Department of Endocrinology and Diabetes, Birmingham Women's and Children's NHS Foundation Trust Birmingham, Birmingham, UK.

出版信息

Eur J Endocrinol. 2021 May;184(5):K15-K20. doi: 10.1530/EJE-20-0152.

DOI:10.1530/EJE-20-0152
PMID:33690157
Abstract

INTRODUCTION

Autosomal recessive forms of pseudohypoaldosteronism are caused by genetic defects in the epithelial sodium channel. Little is known about the long-term outcome and medication needs during childhood and adolescence.

OBJECTIVE

This study reports a single-centre experience of children affected with this ultra-rare condition over a 37-year period.

METHODS

We report the clinical presentation, growth, neuro-development, associated conditions, mortality and medication dosing and administration for 12 affected children from eight families.

RESULTS

All children were presented within the first 2 weeks of life with life-threatening, severe hyperkalaemia and hyponatraemia. All parents were consanguineous and of South Asian, Middle Eastern or African ethnic origin. Eight children had homozygous mutations in the SCNN1A and SCNN1G genes, encoding the epithelial sodium channel subunits alpha and gamma, respectively, including one novel mutation. Three children died (25%) and two (16%) had severe neurological impairment post-cardiac arrest secondary to hyperkalaemia. One affected female had a successful pregnancy at the age of 28 years.

CONCLUSION

Despite high mortality and morbidity in this condition, survival with normal physical and neurological outcome is possible, justifying intensive management to prevent electrolyte imbalance.

摘要

介绍

常染色体隐性遗传型假性醛固酮减少症是由上皮钠通道的基因缺陷引起的。对于儿童和青少年时期的长期预后和药物需求知之甚少。

目的

本研究报告了一个单中心在 37 年期间对患有这种超罕见疾病的儿童的经验。

方法

我们报告了 8 个家庭的 12 名受影响儿童的临床表现、生长、神经发育、相关疾病、死亡率以及药物剂量和管理。

结果

所有儿童均在出生后 2 周内出现危及生命的严重高钾血症和低钠血症。所有父母均为近亲,来自南亚、中东或非洲裔。8 名儿童在 SCNN1A 和 SCNN1G 基因中均存在纯合突变,分别编码上皮钠通道亚基 alpha 和 gamma,包括一个新突变。3 名儿童死亡(25%),2 名(16%)因高钾血症继发心搏骤停后有严重神经功能障碍。一名受影响的女性在 28 岁时成功怀孕。

结论

尽管这种疾病的死亡率和发病率很高,但通过积极的治疗,患儿可能存活下来并具有正常的身体和神经发育,因此有必要进行强化管理以预防电解质失衡。

相似文献

1
Clinical characteristics and treatment requirements of children with autosomal recessive pseudohypoaldosteronism.常染色体隐性遗传性假性醛固酮减少症患儿的临床特征和治疗需求。
Eur J Endocrinol. 2021 May;184(5):K15-K20. doi: 10.1530/EJE-20-0152.
2
Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.两个来自同一小镇的意大利患者中 novel SCNN1A 基因剪接位点突变导致常染色体隐性假性醛固酮增多症 1 型(PHA1)。
Ital J Pediatr. 2021 Jun 16;47(1):138. doi: 10.1186/s13052-021-01080-x.
3
Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1.五个导致常染色体隐性假性醛固酮增多症 1 型的 SCNN1A 基因突变。
Eur J Endocrinol. 2013 Apr 15;168(5):707-15. doi: 10.1530/EJE-12-1000. Print 2013 May.
4
An unusual case of Pseudohypoaldosteronism coexisting with cystic fibrosis.假性醛固酮减少症合并囊性纤维化的罕见病例。
BMJ Case Rep. 2024 Jun 24;17(6):e260221. doi: 10.1136/bcr-2024-260221.
5
Critical points in the management of pseudohypoaldosteronism type 1.1型假性醛固酮减少症管理中的关键点
J Clin Res Pediatr Endocrinol. 2011;3(2):98-100. doi: 10.4274/jcrpe.v3i2.20. Epub 2011 Jun 8.
6
Novel homozygous mutation in SCNN1A gene in an Iranian boy with PHA1B.伊朗一男孩患 PHA1B,其 SCNN1A 基因中存在新型纯合突变。
J Pediatr Endocrinol Metab. 2024 Jul 5;37(8):745-749. doi: 10.1515/jpem-2023-0505. Print 2024 Aug 27.
7
Diagnostic and management considerations in pseudohypoaldosteronism type 1b.1b 型假性醛固酮增多症的诊断和治疗注意事项。
BMJ Case Rep. 2022 Jan 3;15(1):e246538. doi: 10.1136/bcr-2021-246538.
8
Systemic Pseudohypoaldosteronism Type 1 due to 3 Novel Mutations in SCNN1Aand SCNN1BGenes.系统性假性醛固酮减少症 1 型:3 个 SCNN1A 和 SCNN1B 基因突变所致。
Horm Res Paediatr. 2019;91(3):175-185. doi: 10.1159/000498860. Epub 2019 Apr 24.
9
Novel mutations in the SCNN1A gene causing Pseudohypoaldosteronism type 1.SCNN1A 基因中的新型突变导致 1 型假性醛固酮减少症。
PLoS One. 2013 Jun 6;8(6):e65676. doi: 10.1371/journal.pone.0065676. Print 2013.
10
Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.病例报告:1型假性醛固酮减少症导致的严重新生儿高钾血症。
Curr Opin Pediatr. 2009 Apr;21(2):269-71. doi: 10.1097/MOP.0b013e328325a55f.

引用本文的文献

1
The Epithelial Sodium Channel-An Underestimated Drug Target.上皮钠离子通道:一个被低估的药物靶点。
Int J Mol Sci. 2023 Apr 24;24(9):7775. doi: 10.3390/ijms24097775.
2
Diagnostic and management considerations in pseudohypoaldosteronism type 1b.1b 型假性醛固酮增多症的诊断和治疗注意事项。
BMJ Case Rep. 2022 Jan 3;15(1):e246538. doi: 10.1136/bcr-2021-246538.